Herling, Carmen D.
Cymbalista, Florence
Groß-Ophoff-Müller, Carolin
Bahlo, Jasmin
Robrecht, Sandra
Langerbeins, Petra
Fink, Anna-Maria
Al-Sawaf, Othman http://orcid.org/0000-0001-9895-0570
Busch, Raymonde
Porcher, Raphael
Cazin, Bruno
Dreyfus, Brigitte
Ibach, Stefan
Leprêtre, Stéphane
Fischer, Kirsten
Kaiser, Florian
Eichhorst, Barbara
Wentner, Clemens-Martin
Hoechstetter, Manuela A.
Döhner, Hartmut
Leblond, Veronique
Kneba, Michael
Letestu, Remi
Böttcher, Sebastian
Stilgenbauer, Stephan
Hallek, Michael
Levy, Vincent
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB1074, KFO286)
European Commission / BMBF
Deutsche Krebshilfe (106142, 107080)
Roche Pharma AG, Grenzach, Germany
Agence Nationale de la Recherche (not available)
Article History
Received: 12 June 2019
Revised: 20 January 2020
Accepted: 6 February 2020
First Online: 18 February 2020
Compliance with ethical standards
:
: CDH received research funding and travel support from Roche. PL and KF received travel support from Roche. JB received consulting honoraria and travel support from Roche. MH and CMW report advisory board membership for Roche, and obtained research funding, consulting honoraria, and speaker’s honoraria from Roche. SB reports consulting fees, honoraria, and research funding from Roche. SS declares advisory board membership, consulting honoraria, speaker’s honoraria, research grants and travel support from Roche. All other authors declare no competing financial interests.